XML 25 R10.htm IDEA: XBRL DOCUMENT v3.20.2
Fair Value Measurements
6 Months Ended
Jun. 30, 2020
Fair Value Disclosures [Abstract]  
Fair Value Measurements
4.
Fair Value Measurements
The Company measures and reports its cash equivalents, restricted cash, warrant liabilities and securities issuance obligation at fair value. The following table sets forth the fair value of the Company’s financial assets measured on a recurring basis by level within the fair value hierarchy:
 
   
June 30, 2020
 
   
Level 1
   
Level 2
   
Level 3
   
Total
 
   
(in thousands)
 
Financial Assets
  
Money market funds
  $120,977   $  $  $120,977 
Restricted money market funds
   300 
  
  
 
  
 
     300 
Total financial assets
  $121,277   $  $  $121,277 
  
 
 
   
 
 
   
 
 
   
 
 
 
 
   
December 31, 2019
 
   
Level 1
   
Level 2
   
Level 3
   
Total
 
   
(in thousands)
 
Financial Assets
  
Money market funds
  $146,240   $—    $—    $146,240 
Restricted money market funds
   300    —      —      300 
  
 
 
   
 
 
   
 
 
   
 
 
 
Total financial assets
  $146,540   $—    $—    $146,540 
  
 
 
   
 
 
   
 
 
   
 
 
 
Financial Liabilities
        
Warrant liabilities
  $—    $—    $45,935   $45,935 
Securities issuance obligation
   —      —      10,485   10,485 
  
 
 
   
 
 
   
 
 
   
 
 
 
Total financial liabilities
  $—     $—    $56,420  $56,420 
  
 
 
   
 
 
   
 
 
   
 
 
 
Money market funds and restricted money market funds are measured at fair value on a recurring basis using quoted prices and are classified as a Level 1 input.
The Company’s warrant liabilities and securities issuance obligation contained unobservable inputs that reflected the Company’s own assumptions in which there was little, if any, market activity at the measurement date. Accordingly, the Company’s warrant liabilities were measured at fair value on a recurring basis using unobservable inputs until such time the warrants were no longer considered derivative instruments. The changes in fair value of warrant liabilities were recognized as a component of other income (expense), net in the accompanying condensed consolidated statement of operations for the six months ended June 30, 2020. The securities issuance obligation was measured at fair value on a recurring basis using unobservable inputs until the common stock and the common stock warrant were issued. The change in fair value of the securities issuance obligation was recognized as research and development expense in the accompanying condensed consolidated statement of operations for the six months ended June 30, 2020. The warrant liabilities and the securities issuance obligation were classified as Level 3 inputs.
The assumptions used in calculating the estimated fair values represented the Company’s best estimate. However, inherent uncertainties are involved. If factors or assumptions change, the estimated fair values could be materially different.
At January 22, 2020, Warrant A and Warrant B were no longer considered to be derivative instruments. The Company remeasured the fair value of the warrant liabilities at the time of reclassification to equity using the following assumptions:
 
   
Series A
 
Warrant
  
Series B
 
Warrant
 
Expected term (in years)
   5.0   2.1 
Expected volatility
   43  88
Risk-free interest rate
   1.57  1.53
Expected dividend yield
     
At January 31, 2020, the securities issuance obligation was settled by the issuance of common stock and a common stock warrant. The Company remeasured the fair value of its common stock issuance obligation based on the value of the common stock at the time of issuance. The warrant issuance obligation was remeasured using the following assumptions:
 
   
Warrant
 
Issuance
Obligation
 
Expected term (in years)
   5.0 
Expected volatility
   43
Risk-free interest rate
   1.57
Expected dividend yield
   
 
The following table provides a summary of changes in the estimated fair values of the Company’s Level 3 financial liabilities:
 
   
Series A
 
Warrant
Liability
  
Series B
 
Warrant
Liability
  
Warrant
 
Issuance
Obligation
  
Common
 
Stock
Issuance
 
Obligation
  
Total
 
   
(in thousands)
 
Balance, December 31, 2019
  $32,616  $13,319  $3,036  $7,449  $56,420 
Changes in fair value
   11,597   4,643   152   1,333   17,725 
Settlement of financial liabilities by securities issuance
   —     —     (3,188  (8,782  (11,970
Reclassification to equity
   (44,213  (17,962  —     —     (62,175
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
Balance, June 30, 2020
  $  $  $  $  $ 
  
 
 
  
 
 
  
 
 
  
 
 
  
 
 
 
There were no transfers between Levels 1, 2 or 3 during the six months ended June 30, 2020.